Advertisement

Topics

Latest "Midazolam Proves Choice Pediatric Dental Procedures" News Stories

00:35 EST 21st November 2018 | BioPortfolio

Here are the most relevant search results for "Midazolam Proves Choice Pediatric Dental Procedures" found in our extensive news archives from over 250 global news sources.

More Information about Midazolam Proves Choice Pediatric Dental Procedures on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Midazolam Proves Choice Pediatric Dental Procedures for you to read. Along with our medical data and news we also list Midazolam Proves Choice Pediatric Dental Procedures Clinical Trials, which are updated daily. BioPortfolio also has a large database of Midazolam Proves Choice Pediatric Dental Procedures Companies for you to search.

Showing "Midazolam Proves Choice Pediatric Dental Procedures" News Articles 1–25 of 6,600+

Wednesday 21st November 2018

Apollo Endosurgery Inc APEN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryApollo Endosurgery Inc Apollo Endo, formerly Lpath Inc, is a medical technology company that designs, develops and commercializes medical devices used for the treatment of obesity. The company's product portfolio comprises endobariatric products such as Orbera Intragastric Balloon System and OverStitch endoscopic suturing system; and LapBand system for laparoscopic bariatric surgeries. Thes...


Tuesday 20th November 2018

NYU Langone Medical Center Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryNYU Langone Medical Center NYU LMC a subsidiary of New York University School of Medicine is an academic healthcare center that provides patient care, education and research services. The center offers patient care services such as patient and family support; imaging services, medical services, emergency care; and insurance and billing. It provides medical degree programs, clinical trials, ...

APEIRON Biologics AG Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryAPEIRON Biologics AG APEIRON is a clinicalstage biotechnology company that concentrates on the development of biological and immunological solutions for the treatment of various cancers. The company's pipeline products include APN01, APN301, APN311, APN401, APN411, APN421 and APN431. Its APN311 is an antibodybased therapy used for the treatment of highrisk neuroblastoma. APEIRON's APN301 is...


InVitae Corp NVTA Medical Equipment Deals and Alliances Profile [Report Updated: 12092018] Prices from USD $250

SummaryInvitae Corp Invitae, formerly Locus Development Inc, is a genetic information company which processes DNAcontaining samples, analyzes information about patientspecific genetic variation and generates test reports for clinicians and their patients. The company's portfolio of diagnostic tests includes preimplantation and carrier screening for inherited disorders, miscarriage analysis, neurol...

Advicenne SA ADVIC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27082018] Prices from USD $250

SummaryAdvicenne SA Advicenne is a developer of pediatric medicines. The company offers product portfolio such as ADV6209, a liquid formulation of a benzodiazepine for moderate sedation and anesthetic premedication; ADV7103, a formulation in the form of microtablets for renal tubulopathies. It provides its products for the treatment of neurological diseases and renal disorders in children. Advicen...

Florida Judge Rules for AHF in Medicaid Contract Case Involving Health Coverage of Thousands with HIV

Florida Division of Administrative Hearings’ Judge issues a Recommended Order upholding AHF’s legal contentions in case involving the state’s denial of the renewal of an HIV care contract with AHF’s Positive Healthcare, a denial that would disrupt care for nearly 2,000 Florida HIV patients. After a nearly two-decade partnership, Florida Ag...

Fuse Medical, Inc. Ranked No. 56 Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500TM

Fuse Medical, Inc., (OTC: FZMD), (“Fuse” or the “Company”), a contract manufacturer and national distributor of medical devices, announced that it has been named Number 56 on the Deloitte’s 2018 Technology Fast 500TM (“Technology Fast 500TM”), an annual ranking of the fastest growing North American companies in the technology, media, telecomm...

New Lecture Added to Essential Dental Seminars 2019 Roster

Join Essential Dental Seminars in Grand Rapids for Acclaimed Hands-On Endodontic Course GRAND RAPIDS, Mich. (PRWEB) November 20, 2018 Join Essential Dental Seminar's Safe and Efficient Root Canal Treatment lecture to be held in Grand Rapids, Michigan. This course is part of the acclaimed lecture and hands on series given by Dr. Scott Graham. Increase your Endodontic skills, network with denti...

FDA Approves Gamifant, the First and Only Treatment Indicated for Primary Hemophagocytic Lymphohistiocytosis

WALTHAM, Mass.–(BUSINESS WIRE)–Sobi, an international biopharmaceutical company dedicated to rare diseases, and Novimmune SA, a Swiss biotech company, today announced that the U.S. Food and Drug Administration (FDA) has approved Gamifant®(emapalumab-lzsg), an interferon gamma (IFNγ) blocking antibody for the treatment of pediatric (newborn and older) and adult patients with primary ...

Boston Scientific Offers to Buy UK Medical Device Firm BTG for $4.2 Billion

MARLBOROUGH, Mass., Nov. 20, 2018 /PRNewswire/ — Boston Scientific (NYSE: BSX) today announced it has reached an agreement on the terms of a recommended offer to acquire BTG plc. (LSE: BTG), a company headquartered in the United Kingdom, which develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as acute care pharmaceu...

Canada Dental Procedures Outlook to 2025 Crown and Bridge Procedures, Dental Implant Procedures, Dental Membrane Procedures and Dental Polishing Procedures [Report Updated: 10092018] Prices from USD $3995

Canada Dental Procedures Outlook to 2025 Crown and Bridge Procedures, Dental Implant Procedures, Dental Membrane Procedures and Dental Polishing ProceduresSummaryGlobalData's new report, Canada Dental Procedures Outlook to 2025, provides key procedures data on the Canada Dental Procedures. The report provides procedure volumes within market categories Crown and Bridge Procedures, Dental Implant ...

Dementia cure: New vaccine JAB could HALVE Alzheimer’s cases – Express.co.uk

Express.co.ukDementia cure: New vaccine JAB could HALVE Alzheimer's casesExpress.co.ukA new study shows that a vaccine delivered to the skin prompts an immune response that reduces build-up of harmful tau and beta-amyloid - without triggering severe brain swelling that earlier antibody treatments caused in some patients. Prof Roger ...Anti-Alzheimer's vaccine could soon be tested on patients, say ...

Canada Dental Equipment Market Outlook to 2025 [Report Updated: 01092018] Prices from USD $4995

Canada Dental Equipment Market Outlook to 2025SummaryGlobalData's new report, Canada Dental Equipment Market Outlook to 2025, provides key market data on the Canada Dental Equipment market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Dental Infection Control Equipment and Dental Light Cure Equipment.The report also provides c...

FDA OKs First Treatment for Pediatric, Adult Patients with Rare Immune Disease

Officials with the FDA have approved emapalumab (Gamifant) for the treatment of pediatric and adult patients with primary hemophagocytic lymphohistiocytosis (HLH), making it the first FDA-approved drug specifically indicated for this disease.

Prestige Brands Holdings Inc PBH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryPrestige Brands Holdings Inc Prestige focuses on the marketing, sales and distribution of overthecounter OTC healthcare and household cleaning brands. The company offers its products for digestive care; lice treatment, household cleaning; hygiene; oral care; pain relief; pediatric care; skin care; eye care and women's health, besides sleep aids and throat drops. It also offers antacids in C...

Two Thirds of Required Pediatric Post-marketing Drug Studies are Missing

NewsAs a result, most new drug labels continue to lack information needed for use in children, and most FDA-approved medications remain untested in children.

Vizient Employees Complete 8,000 Hours of Community Service during Annual Event

Employees from Vizient, Inc. completed 8000 hours of community service hours as part of the company’s 16th annual Community Day event held on Oct. 16. The event included 75 sites, i

Rite Aid Foundation Gifts More Than $2 Million To KidCents Charities with Thanks For Giving Holiday Program

More Than 400 KidCents Charities to Receive a $5,000 Grant to Improve the Lives of Children In celebration of #GivingTuesday on Nov. 27, a global day of giving fueled by the power of social media, The Rite Aid Foundation is awarding a total of $2.2 million to partner charities through its KidCents Thanks For Giving Holiday program. This special program...

FDA approves $SOBI/NovImmune anti-IFN-𝛾 Emapalumab for pHLH right after #ASH18 late breaker published, awards a Rare Pediatric Disease PRV https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626263.htm … This is FDA CDER NME approval #51

FDA approves $SOBI/NovImmune anti-IFN-𝛾 Emapalumab for pHLH right after #ASH18 late breaker published, awards a Rare Pediatric Disease PRV https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626263.htm … This is FDA CDER NME approval #51 for the yr, 3 more to go to break record of 53 from 1996

While China Investigates Marriott’s Dirty Rooms, UNITE HERE Offers Briefing with Housekeepers

Union offers meeting to explain how Marriott’s “Green Choice” program hurts housekeepers China’s Ministry of Culture and Tourism is currently investigating the cleanliness of Marriott’s luxury hotel rooms in China. UNITE HERE, the union for North America’s hotel workers, has offered to help by arranging a meeting with the real experts: Marr...

FDA Approves Gamifant® (emapalumab-lzsg), the First and Only Treatment Indicated for Primary Hemophagocytic Lymphohistiocytosis (HLH)

− Primary HLH is an ultra-rare syndrome of hyper-inflammation that usually occurs within the first year of life and can rapidly become lethal unless diagnosed and treated – − To date, primary HLH required immediate induction therapy with steroids and chemotherapy to control hyper-inflammation, followed by hematopoietic stem cell transplant, ...

In Theory, Efforts To Curb Smoking Could Offer Template For Reducing Alcohol Deaths. But Reality Is More Murky.

Many roadblocks stand in the way to effectively addressing what has ballooned into a major public health crisis. "It's just so socially acceptable, especially among the people who write the laws," says Boston University professor David Jernigan. "It's the drug of choice and incredibly normalized for upper income people in the USA." In other public health news: the flu shot, contraception, scientif...

Hudson Headwaters joins Aetna’s New York network in Adirondack, North Country and Glens Falls region

Hudson Headwaters Health Network and Aetna (NYSE: AET) announced today a new agreement adding Hudson Headwaters’ system of 17 community health centers in the Adirondacks, North Country and Glens Falls region to Aetna’s New York network. Hudson Headwaters provides primary care to residents in all of Warren County and parts of Clinton, Essex, Hamilton, S...

Patterson Foundation Awards $115,000 in Grants at Its Fall Meeting

At its third quarter board meeting, the Patterson Foundation awarded $115,000 in grant funding to nine nonprofit organizations in the oral and animal health fields. The Patterson Foundation focuses its grants on programs that provide dental care to disadvantaged communities and assistance dogs to veterans and people with disabilities. Here are two of our f...

Permanent J Code Issued for Avedro’s Photrexa® Drug Formulations

J Code 2787, Effective January 1, 2019, Expected to Streamline Reimbursement and Expand Patient Access Avedro, Inc., a leading commercial-stage ophthalmic medical technology company and a global leader in corneal remodeling, today announced that the Centers for Medicare and Medicaid Services (CMS) issued a product-specific J code, J278...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks